Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Biosion Initiates Phase II Clinical Trial of BSI-045B in Atopic Dermatitis 2023-04-04 20:50
Lynk Pharmaceuticals Announces Positive Results for LNK01003 in Phase I Trial in Healthy Subjects 2023-04-04 20:00
iNtRON confirms cancer-controlling effect of PHAGERIA® drug candidate in the organoid model. 2023-04-04 10:33
AnPac Bio-Medical Science Enters into Asset Purchase Agreement with Easy Hundred Inc. 2023-04-03 21:00
GC Cell and New Management Embarking on a New Chapter 2023-04-03 16:47
Harbour BioMed Reports Full Year 2022 Financial Results 2023-04-03 15:10
The World's Second Approved Biosimilars of Denosumab (MAILISHU) 2023-04-03 13:44
CBC Group Appoints Healthcare Veteran Abbas Hussain as Operating Partner 2023-04-01 10:00
Hugel Appointed Suk-yong Cha as Executive Chairman and Chairman of the Board Accelerating Transformation into a Global Top-tier Company 2023-03-31 20:00
I-Mab Provides Business and Corporate Updates and Reports Financial Results for the Year Ended December 31, 2022 2023-03-31 18:30
Genscript Biotech Reports 2022 Annual Results* 2023-03-31 08:40
Kintor Pharma Announces 2022 Annual Results and Recent Business Progress 2023-03-31 00:33
Actinogen presents positive Phase 2a Xanamem data in at ADPD™ Alzheimer's and Parkinson's diseases conference 2023-03-30 21:00
ACROBiosystems' new strategic focus - streamlining the transition from preclinical development to commercialization 2023-03-30 18:54
Zylox-Tonbridge Announces Financial Results for 2022: Revenue Increases by 87.8% YOY to RMB 334 million and Gross Profit Reaches RMB 253 million 2023-03-30 15:49
ImmVira's oncolytic product MVR-C5252 targeting malignant glioma obtained NMPA's approval for Clinical Trial in China 2023-03-30 08:00
bitBiome and Kaken Pharmaceuticals sign joint research agreement on the discovery of drugs for infectious diseases 2023-03-29 22:00
Kintor Pharma Announces Completion of Subject Enrollment in Phase III Clinical Trial of KX-826 for Treatment of Male Androgenetic Alopecia in China 2023-03-28 21:41
Tigermed Reports Full Year 2022 Results 2023-03-28 19:09
OncoVent, a Subsidiary of Hepalink, Enters into a License and Distribution Agreement with Orient EuroPharma for the Immunotherapeutic Candidate Oregovomab 2023-03-28 15:36
1 54 55 56 57 58 220